Hospital
Webster County Memorial Hospital
Webster County Memorial Hospital was paid $1.90M by Medicaid between Jan 2018 and Dec 2021, across 54 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoWEBSTER COUNTY MEMORIAL HOSPITAL
WEBSTER SPRINGS, WV 26288
WEBSTER SPRINGS, WV 26288
33aNPI1699778704assigned 05/23/2005
33bProvider typeCritical Access Hospital
28Total paid$1.90M
24GClaims29,081
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2021
Compared with peers
Next to other Critical Access Hospital providers in West Virginia
Rank by total paid#19 of 24
Median peer was paid$3.57M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,239 | $561K | |
| 2019 | 3,291 | $230K | |
| 2020 | 10,423 | $672K | |
| 2021 | 8,128 | $434K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 3,000 | 2,231 | $261K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.2% | 965 | 722 | $175K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.0% | 3,212 | 2,303 | $151K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.7% | 911 | 693 | $89K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.3% | 438 | 361 | $81K |
| 36415 | Collection of venous blood by venipuncture | 4.3% | 3,251 | 2,191 | $81K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.2% | 974 | 787 | $80K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.0% | 1,308 | 955 | $75K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 3.9% | 260 | 221 | $73K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 3.6% | 321 | 221 | $68K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.6% | 1,027 | 830 | $67K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.5% | 1,766 | 1,409 | $67K |
42 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.0% | 586 | $58K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 920 | $52K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 1,071 | $49K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.5% | 415 | $47K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 688 | $46K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.2% | 889 | $41K |
| 84484 | 2.0% | 423 | $38K | |
| 80061 | Lipid panel | 1.6% | 537 | $30K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.2% | 171 | $23K |
| 82550 | 1.2% | 402 | $22K | |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 191 | $20K |
| 83735 | 1.0% | 464 | $20K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1.0% | 638 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 239 | $19K |
| 83721 | <1% | 440 | $18K | |
| 81003 | <1% | 813 | $17K | |
| 80305 | <1% | 307 | $16K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 637 | $15K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 342 | $13K |
| 82553 | <1% | 97 | $10K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 86 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 68 | $6K |
| 81025 | <1% | 122 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 209 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 85 | $4K |
| A0425 | Ground mileage, per statute mile | <1% | 35 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 137 | $4K |
| 82607 | <1% | 76 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 125 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 72 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 19 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 38 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 38 | $1K |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 22 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 35 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $956.28 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 22 | $916.65 |
| 83605 | <1% | 21 | $823.08 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 22 | $780.96 |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $767.63 |
| 97010 | <1% | 41 | $532.80 | |
| 82746 | <1% | 71 | $433.39 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIFFLE, TINA (CREDENTIALING)